As SII’s Covid-19 vaccine, Covishield, was not yet accepted in these countries students have to incur substantial quarantine costs. Adar Poonawalla, CEO of Serum Institute of India (SII), on Thursday announced that he had created a Rs 10-crore fund to extend financial support to students travelling abroad for education. As SII’s Covid-19 vaccine, Covishield, was … Read more
Rs 9,725.15 crore – that is the vaccination bill for India so far. The Centre has spent Rs 8,071.09 crore to buy vaccines and remaining about Rs 1,654.06 crore on operational costs for administering the vaccines, as per details shared by the health and family welfare ministry in the Lok Sabha on Friday. Giving a … Read more
India pulled back its supply of vaccines to the rest of the world after the second wave of pandemic hit the country, resulting in acute global shortage of COVID-19 vaccines, the Biden Administration has informed the lawmakers. “When the Delta variant is raging around the world and supply is lacking globally because the Serum Institute … Read more
India is vaccinating on an average 50 lakh individuals daily since June 21, equivalent to inoculating the entire population of Norway every day, the Centre said on Friday and asserted that the process is like a “marathon and not a 100-metre race”. Addressing a press briefing, Lav Agarwal, Joint Secretary, health ministry, said till date, … Read more
The EU drug regulator has only approved four Coronavirus vaccines namely- Pfizer/BioNTech, Moderna, AstraZeneca and Johnson & Johnson. Amidst multiple setbacks from European drug regulators, Covishield vaccine, in a significant boost, has been accepted by Switzerland drug regulator along with seven other European countries. According to sources quoted by news agency ANI, apart from Switzerland, … Read more
Serum produced 300 million doses of Covid-19 vaccines till mid-June and the country has administered 28.35 crore Covishield doses till date. Serum Institute of India (SII) CEO Adar Poonawalla on Monday said he was trying to resolve the problems being faced by Indians, who have been vaccinated with Covishield, in travelling to European countries. A … Read more
This would be a new phase in vaccination, he added. The efficacy of the Novavax vaccine in trials augurs well for India as Serum Institute of India (SII) will be producing these doses in India in collaboration with the US firm, VK Paul, member, health, Niti Aayog, said. The vaccine has shown 90% efficacy in … Read more
India may raise spending on COVID-19 shots by over a quarter this fiscal year to up to 450 billion rupees ($6.18 billion) from its budgeted amount, two government sources told Reuters after the prime minister offered free doses to all adults. Prime Minister Narendra Modi said in an address to the nation on Monday that … Read more
Serum is making the Sputnik V dose, which happens to be the second dose, the other is the first dose. (Reuters image) Pune-based Serum Institute of India (SII), which has been the largest producer of vaccines in India, making the Oxford-AstraZeneca vaccine Covishield – hopes to begin manufacture of two more vaccines – Corovax (made … Read more
In the span of just five days last month, China gave out 100 million shots of its COVID-19 vaccines. After a slow start, China is now doing what virtually no other country in the world can: harnessing the power and all-encompassing reach of its one-party system and a maturing domestic vaccine industry to administer shots … Read more